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Mice with infectious colitis exhibit linear growth failure and
subsequent catch-up growth related to systemic inflammation
and IGF-1
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Abstract
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In developing communities, intestinal infection is associated with poor weight gain and lineargrowth failure. Prior translational animal models have focused on weight gain investigations into
key contributors to linear growth failure have been lacking. We hypothesized that murine intestinal
infection with Citrobacter-rodentium would induce linear-growth failure associated with systemic
inflammation and suppressed serum levels of insulin-like growth factor-1 (IGF-1). We evaluated 4
groups of mice infected or sham-infected on day-of-life 28: uninfected-controls, wild-type C.rodentium-infected, partially-attenuated C. rodentium-infected (with deletion of 3 serine protease
genes involved in colonization), and pair-fed (given the amount of daily food consumed by the
wild-type C.-rodentium group). Relative to the uninfected group, mice infected with wild-type C.
rodentium exhibited temporal associations of lower food intake, weight loss, linear-growth failure,
higher IL-6 and TNF-α and lower IGF-1. However, relative to the pair-fed group, the C.rodentium-infected group only differed significantly by linear growth and systemic inflammatory
cytokines. Between post-infection days 15–20, the infected group exhibited resolution of systemic
inflammation. Between days 16–20, both wild-type C.-rodentium and pair-fed groups exhibited
rapid linear-growth velocities exceeding the uninfected and mutant C.-rodentium groups; during
this time levels of IGF-1 increased to match the uninfected group. We submit this as a model
providing important opportunities to study mechanisms of catch-up growth related to intestinal
inflammation. We conclude that in addition to known effects of weight loss, infection with C.
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rodentium induces linear-growth failure potentially related to systemic inflammation and low
levels of IGF-1, with catch-up of linear growth following resolution of inflammation.

Keywords
diarrhea; Citrobacter rodendium; growth failure; inflammation; insulin-like growth factor-1

1. Introduction
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Infectious diarrhea continues to affect children worldwide, with an estimated mortality of
over 700,000 children yearly [1]. While diarrhea-related mortality has decreased over the
past 20 years, morbidity persists, including nutritional deficits, and retardation of linear and
ponderal growth [2]. The underlying mechanisms of poor linear growth in these settings
remain unclear including whether the weight and height deficits are related to decreased
food intake, systemic inflammation, poor absorption of nutrients, and dysregulation of
systemic growth factors such as insulin-like growth factor (IGF)-1 [3, 4]. Persistent length/
height measurement of more than two standard deviations below the mean (i.e., stunting)
affects many of these children, even after resolution of the intestinal infections [5, 6]. Other
children exhibit compensatory catch-up growth, an accelerated growth velocity that partially
or completely normalizes their height [7, 8]. To date, animal models have focused on weight
loss, with few translational animal models to study these complex linear-growth-impacting
phenomena [9].
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One mouse model to study the sequelae of infectious diarrhea involves inoculation with
Citrobacter rodentium [10]. While this bacterial strain is not a human pathogen, it features
virulence factors similar to those of human diarrheagenic pathogens and mimics the effect of
human infectious diarrhea, with prior studies demonstrating significant weight loss, though
the effect on linear growth has not been assessed in detail [11]. The noted weight loss is
potentially related to decreased food intake, poor absorption of nutrients or increased energy
expenditure during infection [10, 11]. However, the pathophysiology related to any linear
growth deficits in this model remains unclear.
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The goal of the current studies is to evaluate and explore temporal relationships between
weight gain, growth failure, and changes in serum levels of IGF-1 and systemic cytokines
over the course of infection with C. rodentium. We hypothesize that mice infected with C.
rodentium (relative to sham-infected mice and relative to pair-fed controls who are only
given as much daily food as the infected mice had consumed) will exhibit poor linear growth
related to systemic inflammation and lower levels of IGF-1. We further hypothesize that
following clearance of their infection, growth-stunted mice will exhibit “catch-up” growth,
to obtain lengths and weights consistent with those of the uninfected group. The results of
these studies provide for a novel and translationally relevant animal model to study
mechanisms of catch up growth following intestinal infection.
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2. Methods and materials
2.1 Animal care and infection
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All animal studies were carried out in strict compliance with the recommendations in the
Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The
protocol was approved by the University of Virginia Animal Care and Use Committee
(protocol number 3894). All efforts were made to keep pain and suffering to a minimum. All
animals were fed Teklad LM-485 laboratory chow 7012, which contains a proprietary
formulation composed of ground corn, dehulled soybean meal, ground oats, wheat
middlings, dehydrated alfalpha meal, soybean oil, corn gluten meal, and mineral and vitamin
premixes (Envigo, Huntingdon, UK). The proximate analysis of the diet is shown in Table 1.
The C. rodentium model was used as described previously [12, 13]. Briefly, over multiple
sets of experiments, 3- to 4-week-old, C57BL/6 mice were purchased from Jackson
Laboratories (Bar Harbor, ME). Mice were divided into 4 groups: those infected with wildtype C. rodentium, with a mutant strain of C. rodentium (with deletions of three serine
protease autotransporters-encoding genes [crc1, crc2 and adca] involved in colonization and
pathogenesis [12, 14]), an uninfected control group sham-treated with phosphate-buffered
saline (PBS) at time of infection, and a group pair-fed the same food quantity as that
consumed by the wild-type C. rodentium mice. We included the mutant strain of C.
rodentium because this strain had been demonstrated to induce less severe colitis compared
to that seen following inoculation with wild-type C. rodentium (unpublished observations).
This permitted analysis of whether any growth-related sequelae persisted even in the absence
of fulminant disease.
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On day of life 28 or 29, mice from the infected groups were inoculated with approximately
1010 colony-forming units (CFU) of wild type C. rodentium ICC-180 or with the isogenic
mutant strain described above. The bacterial inoculum was suspended in 200 uL of PBS and
administered by oral gavage using a 20-gauge intubation needle. Control animals received
200 uL of sterile PBS. Efficacy of infection was assessed by culture; fecal pellets were
collected aseptically from each infected mouse, weighed, and emulsified in PBS. The
number of viable CFU of C. rodentium bacteria per gram of feces was determined by plating
serial dilutions of the samples on medium containing appropriate selective antibiotics [12].
Similarly, separate groups of mice were euthanized by anesthesia and cervical dislocation
and had their colons removed for analysis of colonization. For enumeration of bacteria in the
distal colon, a 2- to 3-cm section of the distal colon was excised. Lumenal contents were
expelled and the colon segment was opened and rinsed thoroughly in PBS to remove fecal
material, homogenized in 1 ml PBS with a Handi-Shear tissue homogenizer (VirTis,
Gardiner, NY), and diluted in PBS for plating on MacConkey agar. Finally, for assessment
of stool quality over time, at specified time points after inoculation, fecal pellets were
evaluated for stool consistency (categorized as solid, solid/soft, soft, watery) and for the
presence of mucus or blood. At the experiment’s end (following blood draw, if applicable),
animals were euthanized via cervical dislocation under anesthesia.
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Weight was measured every-other-day using a digital scale (Tanita Corp., Arlingtron
Heights, IL). Length measurements were performed every 4 days under sedation with
isoflurane using a vaporizer (LEI Medical, Portland, OR) and digital calipers (Fisher
Scientific, Waltham, MA)[15]. All measurements were performed twice; a third
measurement was performed if these measures were greater than 5% different from each
other; the average of these measurements was then used. All length measurements were
performed by a single investigator (MDD). Nose-anus measurements were made with the
animal supine with gentle pressure to extend the neck, measuring from the furthest point on
the animal’s nose to the furthest point on the anus. Length measurements were performed
with the investigator blinded to the treatment group for the first group of mice (N=10 at
baseline for each group). Blinding was not possible for subsequent sets of animals (N=10 for
each group). However, measurements were compared between experiments and were not
significantly different between sets within each group; therefore, data were combined for
anthropometry measurements for each set of experiments.
2.3 Pair-feeding
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Mice were stored in wire-rack cages with chow placed on the wire rack. Food intake was
followed daily by weighing the food on the wire rack plus any portion that had fallen
through, and subtracting from the previous day’s food weight. For all groups except the pairfed group, this daily amount of food consumed was divided by the number of animals in the
cage (up to 5 animals). Pair-fed animals were individually-housed and each pair-fed mouse
was given only enough food to match the previous day’s average per-mouse consumption by
wild-type C. rodentium-infected animals. For pair-fed animals, food that was unconsumed
by an individual mouse at the end of the 24-hour period (an occurrence only noted on days
17–20 post-infection) was weighed and provided to that animal again, in addition to that
day’s food allotment. For calculating total food intake, this unconsumed food portion was
subtracted from what had been provided to the animal the previous day.
2.4 Serum measurements
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For assessment of cytokines and IGF-1, serum was drawn via cardiac puncture under
anesthesia from separate cohorts of animals at time of euthanizing on days 3, 7 and 10 after
infection. An additional cohort of animals had live blood draw via facial vein under
anesthesia performed at 15 days after infection via ophthalmic artery puncture for each
treatment group and then terminal blood draw at day 20. We measured levels of serum
cytokines to assess pro-inflammatory (IL-6 and TNF-α), anti-inflammatory (IL-10) and
adaptive-immune-modulatory (INF-γ) cytokine responses during infection with C.
rodentium. Quantification of serum cytokines was performed by the University of Virginia
Immunology core using Milliplex Mouse Cytokine/Chemokine Panel 1 Assay
(MilliporeSigma, Billerica, MA). Assays were performed according to the manufacturer’s
specifications and analyzed with a Luminex MagPix platform (Luminex Corp., Austin, TX).
Fluorescence intensity from duplicate samples was averaged and transformed into protein
concentration using a calibration curve obtained from recombinant cytokine standards
analyzed with Milliplex Analyst 5.1 software (MilliporeSigma, St. Louis, MO). Serum
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IGF-1 measurement was performed on mouse serum using ELISA (IDS, Tyne & Wear, UK
and Crystal Chem, Downers Grove, IL) according to the manufacturers’ instructions.
2.5 Statistical Analysis
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We assessed data for normality using Excel (Microsoft, Seattle, WA) and Prizm (Graphpad,
San Diego, CA) and log-transformed data for statistical comparison when not normally
distributed (e.g. for serum levels of cytokines). Data are reported as means and standard
error of the mean (SEM). Our primary outcome of interest was difference in length between
the mice infected with wild-type C. rodentium and the pair-fed group. This comparison was
performed using t-tests in Prizm. All other comparisons between groups were performed
using analysis of variance (ANOVA) in Prizm. Because of uncertain mortality among treated
mice, we began with n=20 per group for wild-type C. rodentium, mutant C. rodentium and
pair-fed mice and n=15 for uninfected controls. While we lacked prior variance data to
perform a priori power calculations for the study, given the observed variance in each group
and the number of mice surviving the experiment, we had 80% power to detect a difference
of as little as 0.75-standard deviation (approximately 2% of body length) between the mice
infected with wild-type and the pair-fed group. Statistical significance was considered for
p<0.05. Mice that died before the end of the experiment were included in calculation of
mortality by treatment group but were excluded from calculation of daily weight, length and
food intake by group. Statistical comparison of food consumption amounts between groups
(as well as calculation of SEM) was not valid because all mice who were not in the pair-fed
group had per-mouse quantities calculated for each cage (minimizing the true variation in
food consumption on an individual mouse basis), while pair-fed animals were all fed
identical amounts of the average food consumed by the wild-type C-rodentium mice on a
daily basis.
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3. Results
3.1 Infection efficacy and mortality
Figure 1 shows C. rodentium shedding in stool and colonization in colon of mice following
inoculation with wild-type C. rodentium or mutant C. rodentium. Inoculation resulted in a
high infection efficiency with both wild-type C. rodentium and mutant C. rodentium, with
bacterial shedding that continued above 108 CFA/gr feces, continuing until at least 14 days
after infection. Colonization was higher in mice infected with mice inoculated with wildtype C. rodentium compared to mutant C. rodentium by day 10 after inoculation.
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Table 2 shows stool consistency and the presence of mucus and/or blood for each of the
treatment groups. Uninfected and pair-fed mice maintained solid stool throughout, while
mice infected with wild-type C. rodentium all had affected stools (soft or watery) on days
days 4 and 7 (both p<0.01 vs. uninfected), with all mice exhibiting blood or mucus in stool
by day 7. Mice infected with mutant C. rodentium had a lower degree of soft stools by day 4
(20% soft) and day 7 (60% solid/soft) and did not have blood or mucus.
Mortality was significant among mice with wild-type C. rodentium infection, with 8% by 10
days and 32% by 15 days. One mouse from the mutant C. rodentium group died within 12
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hours of inoculation, leaving a total mortality of 4% for this group. There was one pair-fed
mouse (5%) that died at day 11 of unknown cause. There was no mortality among
uninfected mice.
3.2 Weight gain, linear growth and food intake
Figure 2 shows food intake, weight gain, and length measures by treatment group. Food
intake was relatively stable among uninfected mice and those infected with mutant C.
rodentium (Figure 2A). Mice infected with wild-type C. rodentium exhibited a decrease in
food intake starting day 7 after infection, with a nadir 10 days after infection, followed by a
gradual increase in food intake above that of the uninfected animals by day 14 after
infection. By design, food consumed by the pair-fed group matched the amount of food
consumed by the wild-type C. rodentium group but with a 1-day delay in receiving this
quantity.
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Regarding weight gain, uninfected mice exhibited steady weight gain through the
experiments (Figure 2B). Mice infected with wild-type C. rodentium exhibited a steady
decrease in weight starting 4 days after infection, with a nadir at 13 days. These levels
differed from uninfected mice on days starting at day 5 after infection (ANOVA p<0.05 on
day 5 and p<0.001 thereafter). Mice that were pair-fed the same amount of food as those
with wild-type C. rodentium had weights that were higher than the C. rodentium group until
day 9 (p<0.05); at that point they began losing weight, experiencing a deeper (though not
significantly lower) nadir and more rapid re-gain of weight than seen for the wild-type C.
rodentium this group, with a higher weight on day 17 (p<0.05). Pair-fed mice had weights
that were significantly different from uninfected mice on days 11–15 after infection
(p<0.001) and were different from mice infected with mutant C. rodentium on days 11–15
after infection (p<0.001 for days 11–13 and p<0.05 on day 15). Finally, mice infected with a
mutant strain of C. rodentium exhibited weight gain intermediate between that of the
uninfected (p<0.05 for days 5–17) and wild-type C. rodentium strain (p<0.01 day 11,
p<0.001 days 13–17, and p<0.05 day 19), without frank weight loss but with slower weight
gain. During the time from day 15 to 19, both the wild-type C. rodentium and pair-fed
groups gained weight faster than the uninfected group (p<0.001) and mutant C. rodentium
group (p<0.01).
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Regarding linear growth, mice in the uninfected and mutant C. rodentium groups exhibited
steady linear growth (Figure 2C). Length among mice infected with wild-type C. rodentium
plateaued by day 4 after infection and nose-anus length remained lower than uninfected
mice thereafter (p<0.01 on days 12–16) and lower than pair-fed mice days 12–16 after
infection (p<0.05). Mice that were pair-fed the same amount of food as those with wild-type
C. rodentium exhibited some slowing of linear growth after on day 4 but were not
significantly different than the uninfected mice thereafter. Again, mice infected with a
mutant strain of C. rodentium exhibited linear growth intermediate between that of the
uninfected and wild-type C. rodentium strain that was different from wild-type C. rodentium
at days 12 and 16 (p<0.01). Both the wild-type C. rodentium and the pair-fed mice appeared
to exhibit particularly brisk “catch-up growth” between days 16–20, when interval growth

Nutr Res. Author manuscript; available in PMC 2018 March 01.

DeBoer et al.

Page 7

Author Manuscript

for both the wild-type C. rodentium (p<0.001) and pair-fed (p<0.05) groups was greater than
the uninfected and triple mutant groups.
3.3 Cytokines
Levels of systemic cytokines over the course of the experiment are displayed in Figure 3.
Relative to the uninfected group, mice infected with wild-type C. rodentium exhibited an
increase in levels of IL-6 and TNF-α starting 3 days after infection (for both IL-6 and TNFα p<0.001 on day 15 after infection compared to all other groups). Mice in the pair-fed
group had levels similar to the uninfected group, while mice infected with mutant C.
rodentium displayed intermediate levels.
3.4 IGF-1 levels
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IGF-1 levels over the course of the experiment are shown in Figure 4. Mice in the uninfected
group exhibited a gradual increase in IGF-1 levels over time. By contrast, mice infected with
wild-type C. rodentium experienced a decrease in IGF-1 levels, with a nadir at day 10
(ANOVA compared to uninfected group p<0.001 days 7–15; lower than the pair-fed group at
day 10, p<0.01). Subsequently there was a rise in IGF-1 levels above those of the uninfected
group. Mice in the pair-fed group exhibited a later nadir in IGF-1 levels to the point where
these were significantly below those of the uninfected group on days 7 and 15 after infection
(p<0.01 and p<0.001, respectively), and also exhibited an dramatic increase by day 20.
Again, mice infected with mutant C. rodentium had IGF-1 levels that were intermediate
between wild-type C. rodentium and uninfected mice and were significantly different from
wild-type C. rodentium at days 7–15 (p<0.001) and different from the pair-fed group on
days 7 (p<0.05) and 15 (p<0.001).
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4. Discussion
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While weight loss during infection with C. rodentium has been previously characterized, we
have expanded assessment of the model to reveal linear growth failure during infection,
followed by subsequent “catch-up” growth that outpaces the growth of uninfected animals.
In this sense, we accepted our research hypothesis that mice infected with C. rodentium
would exhibit linear growth failure. While weight loss in this model have been investigated
[10], this is the first in-depth look into potential contributors to linear growth failure. The
linear growth characteristics are similar to what is frequently seen children in developing
areas worldwide, who frequently experience intestinal infections and have related shortfalls
in linear growth [5] and for whom predictors of catch-up growth have remained elusive [9].
This model may serve as a novel means of assessing mechanisms of linear growth
suppression and subsequent acceleration during onset and clearance of intestinal infections.
These data may thus have significance for testing optimal interventions to improve growth in
the setting of recurrent infections.
In this model, we were particularly interested in the relationships between nutrition,
inflammation and growth. Poor weight gain in this setting was most strongly associated with
a sharp decrease in food intake among infected animals. Mice infected with wild-type C.
rodentium responded to infection with a decrease in food consumption and had a similar

Nutr Res. Author manuscript; available in PMC 2018 March 01.

DeBoer et al.

Page 8

Author Manuscript

drop in weight as mice that were pair-fed the same amount of food as was consumed by the
infected group. This apparent decrease in appetite has been noted previously in models of C.
rodentium infection [16], though in evaluating growth responses to infection between
infected and pair-fed groups, other investigators have assessed weight gain alone and not
linear growth [17, 18].
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In the current set of experiments, linear growth did not appear to be as tightly associated
with nutrition. For instance, animals in the infected group exhibited a more significant linear
growth faltering than those in the pair-fed group. While these observations are novel in the
setting of C. rodentium infection, prior models of intestinal inflammation, such as following
administration of trinitrobenzene sulfonic acid (TNBS), have also reported a greater degree
of linear growth deficits among treated animals compared to pair-fed animals [19]. Animals
with TNBS colitis given gavage feeding to deliver the same amount of calories consumed by
the control group showed increases in weight gain, yet linear growth remained partially
suppressed [19]. This suggested influences beyond the delivery of calories alone. Growth
deficits not explained by nutrition alone have been proposed to result predominantly from
inflammation [19, 20, 21, 22, 23, 24] or from suppression of growth factors in the setting of
inflammation [25, 26].
With respect to the suppression of growth factors in our model, we noted lower levels of
IGF-1 among mice infected with wild-type C. rodentium relative to the uninfected group at
multiple time points and relative to the pair-fed group at day 10. Suppressed levels of IGF-1
have been noted in both states of malnutrition [4, 27, 28] and systemic inflammation [26, 29,
30]. In both of these scenarios, the low levels of IGF-1 appeared to result from growth
hormone resistance at the level of the liver [28, 29, 30, 31, 32].
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The mechanism for IGF-1 suppression among wild-type C. rodentium-infected animals in
our model may be related to both inflammation and low food intake, given that 1) IGF-1
levels were initially lower in infected compared to pair-fed animals, 2) by day 15, infected
and pair-fed animals later had similar levels of IGF-1 and 3) by day 20, infected and pair-fed
animals had similar recovery (in fact, above levels seen among uninfected animals). Thus,
whereas IGF-1 did not appear to play a central role in growth suppression in the later stages
of infection and recovery, the role of IGF-1 in the initial suppression of growth in this model
requires further evaluation. Furthermore, assessment for resistance to IGF-1 in the tissue is
also warranted in this setting [33, 34].
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With respect to systemic inflammation, however, there was a clear separation among the
treatment groups, with levels of IL-6 that were elevated by day 3 after infection and
remained elevated up to day 15. Levels of cytokines did not normalize until day 20 after
infection, and this normalization was associated with a rapid increase in linear growth. This
increase in linear growth was not seen in the pair-fed group, who exhibited low levels of the
systemic inflammatory cytokines IL-6 and TNF-α. In this way, it appeared that the linear
growth suppression among C. rodentium-infected mice was most strongly associated with
these elevations in systemic inflammation. Clearly, more definitive investigations are needed
to identify whether this suppression relates to direct effects of inflammatory and/or other
cytokines at the growth plate itself or through other mechanisms [34, 35].
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Our data suggest that catchup growth relates to both increased appetite and increased
physiologic anabolic response to caloric intake. If these phenomena prevail as well in
children, it would suggest the importance of assuring additional calories in the wake of an
inflammatory infection. One important consideration regarding growth suppression in
developing areas of the world is whether the growth deficits in early childhood: 1) are
permanent, resulting in short adult height 2) will result in a delayed cessation of growth,
resulting in normal adult height or 3) will resolve during early childhood, resulting in catchup growth that normalizes (or partially normalizes) height. Catch-up growth is recognized as
an important process for children who have experienced growth suppression in early
childhood [9]. Catch-up growth has been described as “a height velocity above the statistical
limits of normality for age or maturity during a defined period of time, following a transient
period of growth inhibition; the effect of catch-up growth is to take the child towards his/her
pre-retardation growth curve [8].” However, the predictors and mechanisms of catch-up
growth remain poorly understood [9], and animal models are needed to assess whether
catch-up growth is related to hormonal changes or to changes at the level of the growth
plate, including a delay in senescence and increased proliferation of cells at the growth plate
[9, 36]. Further research is needed in disease states involving mixed processes of
inflammation and nutrition deficits to determine if catch-up growth is more strongly related
to resolution of one process over the other. We submit that the model of catch-up growth
following infection with C. rodentium represents a model of intestinal infection that could be
used to assess these underpinnings of catch-up growth.
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Mice infected with wild-type C. rodentium had a much more severe growth response than
mice infected with a mutant strain of C. rodentium. This mutant strain was deficient in 3
genes that belong to the serine protease autotransporters of Enterobacteriaceae (SPATEs)[12,
14]. These genes appear to be important for colonization and pathogenesis, potentially
accounting for the decrease in virulence of this strain and the relative preservation of weight
gain and linear growth, though this remains to be further characterized. Clearly, the data in
these experiments are observational in nature; continued work using this model will be
needed to determine the exact mechanisms of growth suppression in these settings. For
example, we lacked data regarding shedding and intestinal colonization up to day 20 postinfection as well as data linking the degree of shedding and colonization to the degree of
growth failure and were thus unable to determine the exact role of on-going infection and
recovery on subsequent catch-up growth. Multiple other questions of pathogen-specific
mechanism remain. C. rodentium is an attaching and effacing pathogen, similar to
enteropathogenic E. coli (EPEC). Further experiments are required to determine whether this
degree of growth failure might be associated with other pathogens, including
Campylobacter, Cryptosporidium and enteroaggerative E. coli—and whether the growth
failure is directly related to the virulence of the organism. Assessment of intestinal
colonization using RT-PCR would improve sensitivity and specificity of detection of the
type of microorganism involved. Finally, further research regarding intestinal infectious
models should also be focused on the relationship between intestinal barrier function,
classical intestinal morphology, local inflammatory biomarkers and linear growth failure.
This study also had several methodological limitations. Animal length was measured in all
animals using general anesthesia to provide the opportunity to have repeated measures in
Nutr Res. Author manuscript; available in PMC 2018 March 01.
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each animal over the course of treatment, (as has been described previously [19, 37]); any
effect of this on the animal is not clear but would have been expected to affect all animals
equally. While the measurements we used are customary, they examine the axial skeleton
only. Femur length would be the best surrogate measure to examine the appendicular
skeleton. We only followed animals for 20 days after infection, to an absolute age of 48–49
days. This is a time point when mice are growing at a noticeable rate. Nevertheless, the
importance of catch-up growth (or the lack thereof) relates most to whether adult height is
preserved. This requires longer follow-up time and may be problematic in rodents, in whom
growth plates do not reach complete fusion as seen in humans. Further assessment will be
needed to assess whether mice infected with C. rodentium reach a similar near-final length
as uninfected animals.
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In conclusion, we found that infection with wild type C. rodentium resulted in poor weight
gain and linear growth failure—similar to growth patterns observed in early childhood in
developing areas of the world where enteral infections are endemic. In this model, infection
was associated with low levels of IGF-1, similar to food-restricted animals. Overall, growth
suppression was most closely linked to elevations in systemic inflammatory cytokines. More
investigations using this model are needed to further determine specific mechanisms
suppressing growth during intestinal infection.
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CFU

colony-forming units

INF-γ

interferon-γ

IL-6

interleukin-6

IL-10

interleukin-10

IGF-1

insulin-like growth factor-1

PBS

phosphate-buffered saline

TNBS

trinitrobenzene sulfonic acid

TNF-α

tumor necrosis factor-α
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Figure 1. C. rodentium bacterial shedding and colonization following infection

Values are means (+/− SEM) colony forming units (CFU) of C. rodentium bacteria per gram
of stool (A, shedding data) or per gram of colon (B, colonization data) following inoculation
with wild type C. rodentium or mutant C. rodentium. § p<0.05 vs. mutant C. rodentium; §§
p<0.001 vs. mutant C. rodentium
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Figure 2. Food intake, weight gain and linear growth measures over the course of experiment
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Values are means (+/− SEM) by treatment group for animals infected with wild type
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups: A. daily food
intake. B. weight; C. length, nose-to-anus. Significance between groups: * p<0.05 vs.
uninfected; ** p<0.01 vs. uninfected; § p<0.05 vs. mutant C. rodentium; §§ p<0.01 vs.
mutant C. rodentium † p<0.05 vs. pair-fed.
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Figure 3. Serum cytokine levels over the course of experiment

Values are means (+/− SEM) by treatment group for animals infected with wild type
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups (see text for
details): A. IL-6; B. TNF-α; C. IL-10; D. interferon γ. All units are in pg/mL. Significance
between groups: * p<0.001 vs. uninfected; § p<0.001 vs. mutant C. rodentium; † p<0.001
vs. pair-fed.
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Figure 4. Serum IGF-1 levels over the course of experiment

Means (+/− SEM) of IGF-1 by treatment group for animals infected with wild type
Citrobacter rodentium, mutant C. rodentium, uninfected, and pair-fed groups. Statistical
significance between groups: * p<0.01 vs. uninfected; ** p<0.001 vs. uninfected; § p<0.05
vs. mutant C. rodentium; §§ p<0.001 vs. mutant C. rodentium; † p<0.01 vs. pair-fed.
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5.8
44.3
4.6
3.1
25
17
58

Fat (%)

Carbohydrate (%)

Crude fiber (%)

Energy density (kcal/g)

Calories from protein (%)

Calories from fat (%)

Calories from carbohydrate (%)

The major ingredients of this diet are described in the methods and materials section.

19.1

Crude protein (%)
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Composition of Teklad LM-485 laboratory chow fed to mice.
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0
0
0

Soft/solid

Soft

Watery

0

Mucus

0

0
0

Soft

0
0

Bloody

Mucus

Blood or mucus present (percent of mice)

Watery

0

0

Soft/solid

0

0

0

100

100

0

0

0

0

0

100

Solid

Stool consistency (percent of mice)

0

Bloody

Blood or mucus present (percent of mice)

100

Solid

Stool consistency (percent of mice)

Pair-fed

40

60

40

60

0

0

20

0

20

80

0

0

Wild type C. rodentium

0

0

0

40

60

0

0

0

0

20

0

80

Mutant C. rodentium

Values are percentages based on n=10 mice per group, with the exception of day 10 wild type C. rodentium, based on n=6 mice.

*

Day 10

Day 4

Uninfected
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Stool consistency and presence of blood and mucus in mice
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